文献速递消化系统肿瘤妇科肿瘤

错配修复基因突变与Lynch综合征癌症发病年龄的关联:分层监测策略的意义

Association of Mismatch Repair Mutation With Age at Cancer Onset in Lynch Syndrome: Implications for Stratified Surveillance Strategies.
PubMed 文献 · JAMA Oncol · 2017-01-01

这项回顾性队列研究纳入1063例确诊Lynch综合征个体,分析突变基因与突变类型对结直肠癌、子宫内膜癌和卵巢癌发病年龄的影响。结果显示MSH6突变者发病较晚,MLH1截短突变女性子宫内膜癌发病晚于非截短突变者。作者认为可按突变基因和类型进行风险分层监测。

要点

  • MSH6突变者结直肠癌和子宫内膜癌发病年龄晚于MSH2或MLH1突变者。
  • MLH1截短突变女性子宫内膜癌发病中位年龄比非截短突变者晚6.6年(95%CI 2.7-10.4,P=0.002)。
  • MLH1截短突变者结直肠癌发病较其他突变者晚,但差异无统计学意义。

核心结论

  • 已知Lynch综合征个体可按突变基因和突变类型进行风险分层并制定个体化监测方案。
  • 具体而言,MSH6突变者可较晚开始癌症监测。
  • MLH1截短突变者可较非截短突变者更晚开始子宫内膜癌监测。

研究设计与样本

  • 回顾性队列研究,纳入英格兰西北部一家大型基因组医学四级转诊中心临床数据库中的Lynch综合征相关结直肠癌、子宫内膜癌和/或卵巢癌个体。
  • 共纳入1063例确诊Lynch综合征个体,495例男性、568例女性,平均年龄52岁,年龄范围10-93岁(数据库包含儿童,但无儿童发生癌症)。
  • 暴露因素为突变基因(MLH1、MSH2、MSH6和/或PMS2)和突变类型(截短、剪接或大片段重排)。
  • 主要结局指标为癌症诊断年龄。
  • 546例男性和女性患结直肠癌,162例女性患子宫内膜癌,49例女性患卵巢癌;平均随访68.2个月。

主要发现

  • 在MLH1突变携带者中,MLH1突变与结直肠癌相关249/409例(61%);子宫内膜癌53/196例(27%);卵巢癌15/196例(8%)。
  • 在MSH2突变携带者中,MSH2突变(总体上最常见的突变)最常与女性特异性癌症相关:子宫内膜癌83/279例(30%);卵巢癌28/279例(10%);结直肠癌239/479例(50%)。
  • MSH6突变较少见,MSH6突变携带者结直肠癌和子宫内膜癌发病年龄晚于MSH2或MLH1突变携带者。
  • 按突变类型分层,MLH1截短突变女性子宫内膜癌发病年龄晚于非截短突变者(中位差6.6年;95%CI 2.7-10.4;P=0.002)。
  • MLH1截短突变携带者结直肠癌发病年龄晚于其他突变者,但差异无统计学意义。

临床怎么用

  • 作者认为,已知Lynch综合征个体可按突变基因和突变类型进行风险分层并制定个体化监测方案。
  • 作者认为,MSH6突变者可较晚开始癌症监测。
  • 作者认为,MLH1截短突变者可较非截短突变者更晚开始子宫内膜癌监测。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Lynch syndrome is caused by dominantly inherited germline mutations that predispose individuals to colorectal, endometrial, ovarian, and other cancers through inactivation of the cellular mismatch repair system. Lynch syndrome–associated cancers are amenable to surveillance strategies that may improve survival. The age at which surveillance should start is disputed. OBJECTIVE: To determine whether mutated gene and type of mutation influence age at onset of Lynch syndrome–associated cancers. DESIGN, SETTING, AND PARTICIPANTS: A retrospective cohort study of individuals with Lynch syndrome–associated colorectal, endometrial, and/or ovarian cancers whose medical records were included in the clinical database of a large quaternary referral center for genomic medicine in the Northwest of England. EXPOSURES: Mutated gene (MLH1, MSH2, MSH6, and/or PMS2) and type of mutation (truncating, splicing, or large rearrangement). MAIN OUTCOMES AND MEASURES: Age at cancer diagnosis. RESULTS: A total of 1063 individuals with proven Lynch syndrome were included, 495 male and 568 female (mean age 52 years; age range, 10-93 years [children were included in the database, but no children developed cancer]). There were 546 men and women with colorectal cancer, 162 women with endometrial cancer, and 49 women with ovarian cancer; mean follow-up was 68.2 months. Among MLH1 mutation carriers, mutations in MLH1 were associated with colorectal cancer in 249 (61%) of 409 men and women; endometrial cancer in 53 of 196 (27%) women; and ovarian cancer in 15 (8%) of 196 women. Among MSH2 mutation carriers, mutations in MSH2 (the most prevalent mutations overall) were most commonly associated with female-specific cancers: endometrial cancer in 83 (30%) of 279 women; ovarian cancer in 28 (10%) of 279 women; and colorectal cancer in 239 (50%) 479 men and women. Mutations in MSH6 were less prevalent, and MSH6 mutation carriers presented with colorectal and endometrial cancer at later ages than carriers of mutations in MSH2 or MLH1. When stratified by mutation type, women with truncating MLH1 mutations had later ages of onset of endometrial cancer than those with nontruncating mutations (median difference, 6.6 years; 95% CI, 2.7-10.4; P = .002). Carriers of truncating MLH1 mutations presented with colorectal cancer at later ages than those with other mutations, but the difference was not statistically significant. CONCLUSIONS AND RELEVANCE: Individuals with known Lynch syndrome could be risk stratified by mutated gene and mutation type in tailored surveillance programs. Specifically, individuals with MSH6 mutations could be offered cancer surveillance from a later age. Furthermore, those with truncating MLH1 mutations could begin endometrial cancer surveillance later than those with nontruncating mutations.

来源:JAMA Oncol,查看原文。版权归原作者所有。

引用

  1. Ryan NAJ, Morris J, Green K, et al. Association of Mismatch Repair Mutation With Age at Cancer Onset in Lynch Syndrome: Implications for Stratified Surveillance Strategies. JAMA Oncol. 2017. PMID: 28772289. doi:10.1001/jamaoncol.2017.0619

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。